Anna Wilde Mathews
speaker
275 appearances
5 recordings
1 series
first heard Aug 2017
last heard Sep 2023
Anna Wilde Mathews’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsNo recordings in the last 12 months.Older appearances are listed below; set an alert to hear about the next one.
Appearances
WSJ Your Money Briefing · How to Appeal When Your Health Insurer Rejects a Claim · 28 Jun 2023
podcast
That's a good start.
And those often have links to the more complete explanation of your plan because people don't always understand the ins and outs of their plan.
That's one thing that we found out from this KFF survey.
People don't really always know what their plan covers and what they're going to have to pay out of pocket.
And these plans can be very, very complicated.
In the past, it has sometimes been considered a lifestyle or cosmetic issue.
That thinking is definitely evolving in the medical establishment.
Physicians often now consider obesity not a lifestyle issue, but really a health issue and a medical condition that needs to be treated.
Well, Ozempic is in a category of drugs that work by mimicking the effects of a naturally occurring gut hormone.
which is called for short GLP-1.
GLP-1 drugs contribute to weight loss by suppressing appetite and making you feel full sooner when you eat.
Ozempic and Munjaro are both geared toward people with type 2 diabetes.
The FDA has approved them for that use.
Wegovi is explicitly approved by the FDA for weight loss, for treating obesity.
although the labeling on the drug actually indicates that it's not just for a person who maybe wants to lose a few pounds.
It's really for people who are in the category, the clinical category of obesity, which means they have a BMI of 30 or more, or they can have a BMI of 27 or more and then also have a related health condition such as high blood pressure.
Well, so specifically, Munjaro and Ozempic are approved to treat diabetes.
They are not approved to treat obesity.
So they are really to help with diabetes, with the blood sugar issues.
Wagovi, although it has the identical active ingredient to Ozempic, is explicitly approved for weight loss.
Showing 101–120 of 275 · page 6 of 14
← Previous
Next →